TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biotrans i Nord AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,011
|
939
|
1,345 |
| Financial expenses |
34
|
26
|
14 |
| Earnings before taxes |
-87
|
-183
|
-48 |
| EBITDA |
119
|
-11
|
100 |
| Total assets |
1,298
|
1,652
|
1,205 |
| Current assets |
266
|
407
|
202 |
| Current liabilities |
309
|
458
|
416 |
| Equity capital |
54
|
59
|
66 |
| - share capital |
44
|
45
|
45 |
| Employees (average) |
8
|
8
|
8 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
4.2%
|
3.6%
|
5.5% |
| Turnover per employee |
126
|
117
|
168 |
| Profit as a percentage of turnover |
-8.6%
|
-19.5%
|
-3.6% |
| Return on assets (ROA) |
-4.1%
|
-9.5%
|
-2.8% |
| Current ratio |
86.1%
|
88.9%
|
48.6% |
| Return on equity (ROE) |
-161.1%
|
-310.2%
|
-72.7% |
| Change turnover |
104
|
-410
|
-32 |
| Change turnover % |
11%
|
-30%
|
-2% |
| Chg. No. of employees |
0
|
0
|
-2 |
| Chg. No. of employees % |
0%
|
0%
|
-20% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.